Predictors of Postoperative Complications in Surgery With Pneumoperitoneum in the Trendelenburg Position
Risk Factors for Postoperative Complications in Surgery With Pneumoperitoneum in Trendelenburg Position. Observational Pilot Study
1 other identifier
observational
100
1 country
1
Brief Summary
Evaluate early postoperative complications after surgery in Trendelenburg position with increased intraabdominal pressure (surgery with pneumoperitoneum). Evaluate the relationship between hemodynamic and metabolic changes on perioperative outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2024
CompletedFirst Submitted
Initial submission to the registry
November 6, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 19, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 19, 2026
April 1, 2025
March 1, 2025
2 years
November 6, 2024
March 30, 2025
Conditions
Outcome Measures
Primary Outcomes (11)
Perioperative change in urine NGAL
Measurement of the concentration of neutrophil gelatinase-associated lipocalin (as an early marker of kidney injury) in a urine sample taken from a Foley catheter
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Acute Kidney Injury
According to the KDIGO acute renal injury stage
2 hours after completion of surgery; 1 day after the procedure; 3 days after the procedure.
Perioperative change in serum NGAL
Measurement of the concentration of neutrophil gelatinase-associated lipocalin (as an early marker of kidney injury) in a blood sample
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in serum concentration of Cannabidiol
Measurement of the concentration of cannabidiol (as an early marker of kidney injury) in a blood sample
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery and 2h hours after completion of surgery
Perioperatitve change in urine concentration of Cannabidiol
Measurement of the concentration of cannabidiol (as an early marker of kidney injury) in a urine sample taken from a Foley catheter
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in TBW
Perioperative change in the bioimpedence-based measurement of Total Body Water (TBW)
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in ECW
Perioperative change in the bioimpedence-based measurement of Extracellular Water (ECW)
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in serum pH
As measured by arterial blood gas
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in serum BE
Perioperatitve change in serum Base Excess (BE) As measured by arterial blood gas
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in serum lactate concentration
Perioperatitve change in serum lactate concentration as measured by arterial blood gas
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Perioperatitve change in serum syndecan-1 concentration
Measured by ELISA
Baseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery
Secondary Outcomes (7)
Delirium
Within 7 days after surgery
CVA / TIA
Within 30 days after surgery
Myocardial Ischemia
During hospital stay, within 30 days after surgery
Arrhythmia
During hospital stay, within 30 days after surgery
Atelectasis
During hospital stay, within 30 days after surgery
- +2 more secondary outcomes
Interventions
Laparoscopic surgery (with controlled pneumoperitoneum) in the Trendelenburg position
Eligibility Criteria
Adult patients who undergo elective laparoscopic surgery in the Hadassah Ein-Kerem Medical Center
You may qualify if:
- ASA Class I-IV.
- Planned for laparoscopic surgery in the Trendelenburg position that is expected to last more than 2 hours.
- Planned arterial catheter insertion.
You may not qualify if:
- Pregnancy.
- Planned open abdominal surgery.
- Renal Replacement Therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Reuven Pizovlead
Study Sites (1)
Hadassah Medical Center
Jerusalem, Yerushalaim, Israel
Biospecimen
Blood and urine samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anesthesia Department Chair
Study Record Dates
First Submitted
November 6, 2024
First Posted
November 12, 2024
Study Start
June 19, 2024
Primary Completion (Estimated)
June 19, 2026
Study Completion (Estimated)
June 19, 2026
Last Updated
April 1, 2025
Record last verified: 2025-03